Skip to main navigation
Skip to search
Skip to main content
Fox Chase Cancer Center Home
Help & FAQ
Home
Profiles
Research Units
Research Resources
Research Outputs
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
Gene therapy for ovarian cancer
George Coukos
,
Stephen C. Rubin
Surgery
University of Pennsylvania
Research output
:
Contribution to journal
›
Article
›
peer-review
10
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Gene therapy for ovarian cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Apoptosis
100%
Ovary Cancer
100%
Cell Cycle
100%
Enzyme
100%
Clinical Trial
100%
Prodrug
100%
Cytotoxic Agent
100%
Minimal Residual Disease
100%
Medicine and Dentistry
Ovarian Cancer
100%
Gene Therapy
100%
Patient
25%
Therapeutic Procedure
25%
Combination Therapy
25%
Gene
25%
Cell Cycle
25%
Signal Transduction
25%
Programmed Cell Death
25%
Enzyme
25%
Minimal Residual Disease
25%
Cytotoxic Agent
25%
Gene Transfer
25%
Transduction Mechanism
25%
Target Cell
25%
Biochemistry, Genetics and Molecular Biology
Gene Therapy
100%
Nested Gene
25%
Apoptosis
25%
Cell Cycle
25%
Signal Transduction
25%
Lysozyme
25%
Transfer Gene
25%
Target Cell
25%